MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
No. of Analysts12121413
Avg. Estimate0.240.261.051.21
Low Estimate0.210.2211.08
High Estimate0.260.281.11.52
Year Ago EPS0.260.271.051.05
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
No. of Analysts991413
Avg. Estimate189.9M191.54M770.82M803.9M
Low Estimate187.9M189M759M769M
High Estimate197.06M194.21M787M842M
Year Ago Sales196.5M196.9M771.4M770.82M
Sales Growth (year/est)-3.40%-2.70%-0.10%4.30%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.0.240.230.260.21
EPS Actual0.260.270.30.26
Difference0.020.040.040.05
Surprise %8.30%17.40%15.40%23.80%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
Current Estimate0.240.261.051.21
7 Days Ago0.240.261.041.21
30 Days Ago0.250.261.031.19
60 Days Ago0.250.261.021.16
90 Days Ago0.250.261.021.16
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days1N/A51
Up Last 30 Days2N/A76
Down Last 30 Days211N/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesMYGNIndustrySectorS&P 500
Current Qtr.-7.70%N/AN/A0.26
Next Qtr.-3.70%N/AN/A0.27
Current YearN/AN/AN/A0.08
Next Year15.20%N/AN/A0.12
Next 5 Years (per annum)11.83%N/AN/A0.11
Past 5 Years (per annum)-12.41%N/AN/AN/A